BioLife Solutions, Inc. Stock or Unit Option Plan Expense
BioLife Solutions, Inc. (BLFS) reported Stock or Unit Option Plan Expense of $611.71 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2018-03-09
- BioLife Solutions, Inc. stock or unit option plan expense for the quarter ending 2017-12-31 was -$232.22K, a 636.75% decline year-over-year.
- BioLife Solutions, Inc. stock or unit option plan expense for the quarter ending 2017-09-30 was $274.65K, a 71.91% increase year-over-year.
- BioLife Solutions, Inc. stock or unit option plan expense for the quarter ending 2017-06-30 was $273.44K, a 17.56% increase year-over-year.
- BioLife Solutions, Inc. stock or unit option plan expense for the quarter ending 2017-03-31 was $295.83K, a 518.78% increase year-over-year.
- BioLife Solutions, Inc. stock or unit option plan expense for fiscal 2017 was $611.71K, a 0.12% decline from fiscal 2016.
- BioLife Solutions, Inc. stock or unit option plan expense for fiscal 2016 was $612.44K, a 19.74% increase from fiscal 2015.
- BioLife Solutions, Inc. stock or unit option plan expense for fiscal 2015 was $511.46K.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$232.22K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $42.43K derived: sum of 2 quarters · filed 2018-03-09 | $315.88K derived: sum of 3 quarters · filed 2018-03-09 | $611.71K 10-K · filed 2018-03-09 |
| 2017-09-30 | $274.65K 10-Q · filed 2017-11-09 | $548.10K derived: sum of 2 quarters · filed 2017-11-09 | $843.92K 10-Q · filed 2017-11-09 | $887.19K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $273.44K 10-Q · filed 2017-08-11 | $569.27K 10-Q · filed 2017-08-11 | $612.54K derived: sum of 3 quarters · filed 2018-03-09 | $772.30K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $295.83K 10-Q · filed 2017-05-12 | $339.10K derived: sum of 2 quarters · filed 2018-03-09 | $498.86K derived: sum of 3 quarters · filed 2018-03-09 | $731.46K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | $43.26K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $203.03K derived: sum of 2 quarters · filed 2018-03-09 | $435.63K derived: sum of 3 quarters · filed 2018-03-09 | $612.44K 10-K · filed 2018-03-09 |
| 2016-09-30 | $159.76K 10-Q · filed 2017-11-09 | $392.37K derived: sum of 2 quarters · filed 2017-11-09 | $569.18K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $232.60K 10-Q · filed 2017-08-11 | $280.41K 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $47.81K 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $511.46K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |